Konstantin Poukalov, Director, 10% Owner at Landos Biopharma, Inc. (LABP), bought 433,873 shares at $11.38 ($5.5M) on 2021-02-08, disclosed to the SEC on 2021-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.14 | 27,453 | $306K | 5.6% |
| 2 | $11.14 | 27,453 | $306K | 5.6% |
| 3 | $11.38 | 34,611 | $394K | 7.2% |
| 4 | $11.38 | 34,611 | $394K | 7.2% |
| 5 | $12.53 | 86,671 | $1.1M | 19.7% |
| 6 | $12.53 | 86,671 |
| $1.1M |
| 19.7% |
| 7 | $13.10 | 1,771 | $23K | 0.4% |
| 8 | $13.80 | 64,730 | $893K | 16.2% |
| 9 | $14.60 | 34,951 | $510K | 9.3% |
| 10 | $14.60 | 34,951 | $510K | 9.3% |
| Total | $12.70 avg | 433,873 | $5.5M | 100% |
| Filing → |